Advertisement

Klinische Wochenschrift

, Volume 65, Issue 9, pp 395–399 | Cite as

Delaying carbohydrate absorption in noninsulin-dependent diabetes mellitus: Useful therapy?

  • H. S. Füeßl
Übersicht

Summary

Epidemiological and psychological studies have revealed major difficulties in motivating diabetic patients to observe a long-term dietary regimen. Therefore, manipulation of intestinal digestion or absorption appears to be a feasible therapeutic approach in the management of diabetes. The addition of natural or chemically processed fiber has been shown to decrease both the postprandial and fasting blood glucose in type-2 diabetics by delaying carbohydrate absorption. Recently, selective enzyme inhibitors of glycoside hydrolases in the upper intestine have been found which create a moderate degree of malabsorption of carbohydrates. The postprandial blood sugar response can be reduced by 50%. However, both these forms of treatment may not be accepted by patients because of impalatability or gastrointestinal side effects. At present only short-term studies with each group of substances are available. Whether the reduction of hyperglycemia is sufficient for the prevention of complications must be clarified in long-term trials.

Key words

NIDDM treatment Carbohydrates Delayed absorption 

Abbrevation

NIDDM

Non-insulin dependent diabetes mellitus

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    American Diabetes Association (1979) Principles of nutrition and dietary recommendations for individuals with diabetes mellitus: Diabetes 28:1027–1030Google Scholar
  2. 2.
    Arky RA (1983) Prevention and therapy of diabetes mellitus. Nutr Rev 41:165–173Google Scholar
  3. 3.
    Aro A, Uusitupa M, Voutilainen E, Korhonen T, Siitonen O (1981) Improved diabetic control and hypocholesterolaemic effect induced by long-term dietary supplementation, with guar gum in type 2 (insulin-independent) diabetes. Diabetologia 21:29–33Google Scholar
  4. 4.
    Bantle JP, Laine DC, Castle GW, Thomas JW, Hoogwerf BJ, Goetz FC (1983) Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects. N Engl J Med 309:7–12Google Scholar
  5. 5.
    Blackburn NA, Redfern JS, Jarjis H, Holgate AM, Hanning I, Scarpello JHB, Johnson IT, Read NW (1984) The mechanism of action of guar gum in improving glucose tolerance in man. Clin Sci 66:329–336Google Scholar
  6. 6.
    Burkitt DP, Trowell HC (1975) Refined carbohydrate foods and disease: some implications of dietary fiber. Academic Press, New YorkGoogle Scholar
  7. 7.
    Cahill GF, Etzwiler DD, Freinkel N (1977) “Control” and diabetes. N Engl J Med 294:1004–1005Google Scholar
  8. 8.
    Caspary WF, Graf S (1979) Inhibition of human intestinal alpha-glucosidehydrolases by a new complex oligosaccharide. Res Exp Med (Berlin) 175:1–6Google Scholar
  9. 9.
    Crapo PA, Reaven G, Olefsky J (1977) Postprandial plasma glucose and insulin responses to different complex carbohydrates. Diabetes 26:1178–1183Google Scholar
  10. 10.
    Creutzfeldt W (ed) (1982) Proceedings first international symposium on acarbose: effects on carbohydrate and fat metabolism. International Congress Series 594. Excerpta Medica, AmsterdamGoogle Scholar
  11. 11.
    Dimitriadis G, Tessari P, Gerich J (1983) Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus. Metabolism 32:987–992Google Scholar
  12. 12.
    Eraker SA, Kirscht JP, Becker MH (1984) Understanding and improving patient compliance. Ann Int Med 100:258–268Google Scholar
  13. 13.
    Fuessl HS, Williams G, Adrian TE, Bloom SR (1987) Effect of guar sprinkled over food on glycaemic control, plasma lipids and gut hormones in non-insulin dependent diabetes mellitus. Diabetic Med: in pressGoogle Scholar
  14. 14.
    Gassull MA, Goff DV, Haisman P, Hockaday TDR, Jenkins DJA, Jones K, Leeds AR, Wolever TMS (1976) Effect of unavailable carbohydrate gelling agents in reducing the postprandial glycaemia in normal volunteers and diabetics. J Physiol (London) 259:52P-53PGoogle Scholar
  15. 15.
    Gerard J, Luyckx AS, Lefebvre PJ (1981) Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months. Diabetologia 21:446–451Google Scholar
  16. 16.
    Goto Y, Homma Y, Irie N (1980) Treatment of maturity-onset diabetes mellitus with a glycoside hydrolase inhibitor (Bay g 5421). In: W Creutzfeldt (ed) Frontiers in hormone research, vol 7. Karger, Basle, pp 291–292Google Scholar
  17. 17.
    Grinker JA, Ball GG (1982) Psychological factors in obesity. In: Brodoff BN, Bleicher SJ (eds) Diabetes mellitus and obesity. Williams and Wilkins, Baltimore/London, pp 301–309Google Scholar
  18. 18.
    Hillebrand I, Englert R (1985) Desoxynojirimycinderivate, zwei neue α-Glucosidaseinhibitoren (BAY m 1099 und BAY o 1248) in der ambulanten Behandlung von Typ-II-Diabetikern. Klin Wochenschr [Suppl IV]:80AGoogle Scholar
  19. 19.
    Holloway WDC, Tasman-Jones C, Lee SP (1978) Digestion of certain fractions of dietary fiber in humans. Am J Clin Nutr 31:927–930Google Scholar
  20. 20.
    Holt S, Heading RC, Carter DC, Prescott LF, Tothill P (1979) Effect of gel fibre on gastric emptying and absorption of glucose and paracetamol. Lancet I:636–639Google Scholar
  21. 21.
    Ionescu-Tirgoviste C, Popa E, Sintu E, Mihalache N, Cheta D, Mincu I (1983) Blood glucose and plasma insulin responses to various carbohydrates in type 2 (non-insulin-dependent) diabetes. Diabetologia 24:80–84Google Scholar
  22. 22.
    Jarjis HA, Blackburn NA, Redfern JS, Read NW (1984) The effect of ispaghule (Fybogel and Metamucil) and guar gum on glucose tolerance in man. Br J Nutr 51:371–378Google Scholar
  23. 23.
    Jenkins DJA, Leeds AR, Gassull MA, Cochet B, Alberti KGMM (1977) Decrease in postprandial insulin and glucagon concentration by guar and pectin. Ann Int Med 86:20–23Google Scholar
  24. 24.
    Jenkins DJA, Wolever TMS, Leeds AR, Gassull MA, Haisman P, Dilawari J, Goff DV, Metz GL, Alberti KGMM (1978) Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J 1:1992–1994Google Scholar
  25. 25.
    Jenkins DJA, Wolever TMS, Taylor RH, Barker H, Fielden H, Baldwin JM, Bowling AC, Newman HC, Jenkins AL, Goff DV (1981) Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 34:362–366Google Scholar
  26. 26.
    Jenkins DJA, Wolever TMS, Jenkins AL, Lee R, Wong GS, Josse R (1983) Glycemic response to wheat products: reduced response to pasta but no effect of fiber. Diabetes Care 6:155–159Google Scholar
  27. 27.
    Knatterud G, Klimt CR, Levin ME, Jakobsen ME, Goldner MG (1978) Effect of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: Section VII. Mortality and selected nonfatal events with insulin treatment. JAMA 240:37–42Google Scholar
  28. 28.
    Krejs GJ, Browne R, Raskin P (1980) Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water and electrolytes. Gastroenterology 78:26–31Google Scholar
  29. 29.
    Leeds AR, Bolster N, Truswell AS (1978) Guar gum and glucose absorption: absence of evidence for malabsorption. Proc Nutr Soc 37:89AGoogle Scholar
  30. 30.
    McIvor ME, Cummings CC, Mendeloff AI (1985) Long-term ingestion of guar gum is not toxic in patients with noninsulin-dependent diabetes mellitus. Am J Clin Nutr 41:891–894Google Scholar
  31. 31.
    Minami H, McCallum RW (1984) The physiology and pathophysiology of gastric emptying in humans. Gastroenterology 86:1592–1610Google Scholar
  32. 32.
    Najemnik C, Kritz H, Irsigler K, Laube H, Knick B, Klimm HD, Wahl P, Vollmar J, Bräuning C (1984) Guar and its effect on metabolic control in type II diabetic subjects. Diabetes Care 7:215–220Google Scholar
  33. 33.
    O'Dea K, Nestel PJ, Antonoff L (1980) Physical factors influencing postprandial glucose and insulin responses to starch. Am J Clin Nutr 33:760–765Google Scholar
  34. 34.
    Petzold R, Frerichs H, Selbmann HK, Überla K, Creutzfeldt W, Schöffling K (1975) The natural history of diabetes mellitus: results of a retrospective study. Diabetologia 11:369AGoogle Scholar
  35. 35.
    Pirart J (1978) Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1:168–172Google Scholar
  36. 36.
    Puls W, Keup V, Krause HP, Thomas G, Hoffmeister F (1977) Glucosidase inhibition. A new approach to the treatment of diabetes obesity and hyperlipoproteinaemia. Naturwissenschaften 64:536–537Google Scholar
  37. 37.
    Reaven GM (1983) Therapeutic approaches to reducing insulin resistance in patients with noninsulin-dependent diabetes mellitus. Am J Med 74:109–112Google Scholar
  38. 38.
    Ricketts HT (1979) Editorial statement. Diabetes 19 [Suppl 2]:III-VGoogle Scholar
  39. 39.
    Rollo J (1798) Cases of diabetes mellitus; with the results of the trials of certain acids and other substances in the cure of lues venerea. In the poultry, 3rd edn. Gillet, LondonGoogle Scholar
  40. 40.
    Ruppin H, Bar-Meir S, Soergel KH, Wood CM, Schmitt MG (1980) Absorption of short-chain fatty acids by the colon. Gastroenterology 789:1500–1507Google Scholar
  41. 41.
    Sachse G, Willms B (1979) Effect of the alpha-glucosidase-inhibitor Bay-g-5421 on blood glucose control of sulphony-lurea-treated diabetics and insulin-treated diabetics. Diabetologia 17:287–290Google Scholar
  42. 42.
    Sailer D, Röder G (1980) Treatment of non-insulin dependent diabetic adults with a new glycoside hydrolase inhibitor (Bay g 5421). Drug Res 30:2181–2185Google Scholar
  43. 43.
    Southgate DAT, Bailey FL, Collinson E, Walker N (1976) A guide to calculating intakes of dietary fiber. J Hum Nutr 30:303–313Google Scholar
  44. 44.
    Trowell H (1976) Definition of fiber and hypothesis that it is a protective factor in certain diseases. Am J Clin Nutr 29:417–425Google Scholar
  45. 45.
    Turnbridge R, Wetherill JH (1970) Reliability and cost of diabetic diet. Br Med J 2:78–80Google Scholar
  46. 46.
    University Group Diabetes Program (1970) A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: Section I. Design, methods and baseline results. Section II. Mortality results. Diabetes 19 [Suppl 2]:747–830Google Scholar
  47. 47.
    University Group Diabetes Program (1974) A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: Section V. Evaluation of phenformin therapy. Diabetes 24 [Suppl 1]:65–184Google Scholar
  48. 48.
    Uttenthal LO, Ukponmwan OO, Wood SM, Ghiglione M, Ghatei MA, Trayner IM, Bloom SR (1986) Long-term effects of intestinal alpha-glucosidase inhibition on postprandial glucose, pancreatic and gut hormone responses and fasting serum lipids in type 2 diabetics on sulphonylureas. Diabetic Med 3:155–160Google Scholar
  49. 49.
    Vierhapper H, Bratusch-Marrain A, Waldhäusl W (1978) Alpha-glucoside hydrolase inhibition in diabetes. Lancet II:1386Google Scholar
  50. 50.
    Vierhapper H, Bratusch-Marrain A, Waldhäusl W (1981) Long-term treatment of sulphonylurea-treated diabetics with the alpha-glucosidase inhibitor Bay g 5421 (acarbose). Diabetologia 20:586Google Scholar
  51. 51.
    Walton RJ, Sherif IT, Noy GA, Alberti KGMM (1979) Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor. Br Med J 1:220–221Google Scholar
  52. 52.
    West KM (1973) Diet therapy: an analysis of failure. Ann Int Med 79:425–434Google Scholar
  53. 53.
    West KM, Kalbfleisch JM (1971) Influence of nutritional factors on the prevalence of diabetes. Diabetes 20:99–108Google Scholar
  54. 54.
    Williams G, Fuessl HS, Bloom SR (1987) A long-acting somatostatin analogue (SMS 201–995) reduces postprandial hyperglycaemia in certain obese, insulin-resistant non-insulin dependent diabetic patients. Clin Sci: submittedGoogle Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • H. S. Füeßl
    • 1
  1. 1.Medizinische Poliklinik der Universität MünchenGermany

Personalised recommendations